Genprex
Founded
2009
2009
Geography
United States of America based
United States of America based
Funding
$12.200 M
$12.200 M
Genprex is a clinical stage gene therapy company developing molecular therapies to better target lung cancer cells. Their new approach to treating cancer is based upon our novel proprietary technology platform, including our initial product candidate, Oncoprex immunogene therapy, or Oncoprex.
Technologies
Gene Therapy StartupsR&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet